Tobacco, alcohol use and underlying comorbidities in symptomatic COVID-19 cases versus asymptomatic COVID-19 cases: a case control study in Mumbai city
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20231281Keywords:
Alcohol, Co-morbidities, COVID-19, TobaccoAbstract
Background: Coronavirus disease-2019 belonging to Corona virus family, was first reported in Wuhan, China in November 2019 which is an ongoing Pandemic. The apparent vulnerable group more susceptible to the symptomatic infection are the elderly population, tobacco and alcohol users and people having underlying comorbid conditions.
Methods: An unmatched case-control study was conducted in March 2021 through purposive sampling amongst the Covid-19 infected population. The socio-demographic details, use of tobacco, alcohol and underlying comorbid conditions were studied to show the association with symptomatic Covid-19 infection, in the population more than 18 years of age in Mumbai City.
Results: Out of the total 528 Covid-19 infected individuals, 38.8% were symptomatic and 61.2% were asymptomatic. The elderly population and the underlying comorbid conditions were not found to be associated with symptomatic Covid-19 infection. Alcohol consumption (OR 0.87 (95% CI -0.39, 1.92)), and both alcohol consumption and smoking (OR 0.94[95% CI 0.45, 1.97) association with symptomatic Covid-19 infection were found to be insignificant at 95% CI in the present study whereas significant negative association was observed in smoking (OR 0.21 (95% CI 0.08, 0.53)) with symptomatic covid-19 infection.
Conclusions: Covid-19, addiction and the non-communicable diseases together is a major public health concern in India. Since no significant association was found, study on other unknown factors like the genetics, race, ongoing treatment for underlying comorbid disease and other should be conducted to understand the actual risk factors of the novel disease.
References
Chen Z, Wang B, Mao S, Ye Q. Assessment of global asymptomatic sars-cov-2 infection and management practices from China. Int J Biol Sci. 2021;17(4):1119-24.
Posso M, Comas M, Román M, Domingo L, Javier, Louro et al. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect, the company’ s public news and information. Sci Lett Bronconeumonal. 2020;56(11):747-63.
Kataria I, Jain N, Arora M. COVID-19 and People living with Noncommunicable Diseases in India. Observer Research Foundation (ORF). 2020. Available at https:// www. orfonline. org/expert-speak/ covid19 – and – people – living -with-noncommunicable -diseases-in-india/. Accessed on 12 January 2022.
O’Driscoll M, Ribeiro Dos Santos G, Wang L, Cummings DAT, Azman AS, Paireau J, et al. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2021;590(7844):140-5.
Shivane VK, Lila AR, Bandgar TR. Type 2 diabetic asian indians and covid-19: Lessons learnt so far from the ongoing pandemic. J Postgraduate Med. 2020;66:179-81.
Banerjee M, Pal R, Bhadada SK. Intercepting the deadly trinity of mucormycosis, diabetes and COVID-19 in India. Postgraduate Med J. 2021;7:83-9.
Basu S. Non-communicable disease management in vulnerable patients during Covid-19. Indian J Med ethics. 2020;5:103-05.
Gaur K, Khedar RS, Mangal K, Sharma AK, Dhamija RK, Gupta R. Macrolevel association of COVID-19 with non-communicable disease risk factors in India. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2021;15:343-50.
Biswas M, Rahaman S, Biswas TK, Haque Z, Ibrahim B. Association of sex, age, and comorbidities with mortality in covid-19 patients: a systematic review and meta-analysis. Intervirology. 2021;64(1):36-47.
Yadav R, Acharjee A, Salkar A, Bankar R, Palanivel V, Agrawal S, et al. Mumbai mayhem of COVID-19 pandemic reveals important factors that influence susceptibility to infection. E Clinical Med. 2021;35:6.
Saurabh S, Verma MK, Gautam V, Kumar N, Jain V, Goel AD, et al. Tobacco, alcohol use and other risk factors for developing symptomatic COVID-19 vs asymptomatic SARS-CoV-2 infection: a case-control study from western Rajasthan, India. Trans R Soc Trop Med Hyg. 2021;115(7):820-31.
Chang AY, Cullen MR, Harrington RA, Barry M. The impact of novel coronavirus COVID-19 on noncommunicable disease patients and health systems: a review. J Int Med. 2021;289:450-62.
Mathur P, Rangamani S. COVID-19 and noncommunicable diseases: Identifying research priorities to strengthen public health response. Int J Noncommunicable Dis. 2020;5:76.
Singh AK, Misra A. Impact of COVID-19 and comorbidities on health and economics: focus on developing countries and India, diabetes and metabolic syndrome. Clinical Research Reviews. 2020;14:1625-30.
Gupta PC, Maulik PK, Pednekar MS, Saxena S. Concurrent alcohol and tobacco use among a middle-aged and elderly population in Mumbai. Natl Med J India. 2005;18(2):88-91.
